Abstract
Allergic reactions to penicillin and cephalosporin antibiotics are common. The mechanisms involved are heterogeneous and not yet completely understood. However, clinical and immunologic studies suggest that type I (IgE-mediated) and type IV (cellmediated) pathogenic mechanisms are involved in most immediate and non-immediate reactions, respectively. The diagnostic procedure has recently been standardized under the aegis of the European Network for Drug Allergy and the European Academy of Allergy and Clinical Immunology interest group on drug hypersensitivity. In this review, we describe the general guidelines for evaluating subjects in whom there is suspicion of allergic reactions to β-lactams.
Similar content being viewed by others
References and Recommended Reading
Johansson S, Hourihane J, Bousquet J, et al.: A revised nomenclature for allergy: an EAACI position statement from the EAACI nomenclature task force. Allergy 2001, 56:813–824.
Levine BB: Immunologic mechanisms of penicillin allergy: a haptenic model system for the study of allergic diseases of man. N Engl J Med 1966, 275:1115–1125.
Torres MJ, Blanca M, Fernandez J, et al.: Diagnosis of immediate reactions to beta-lactam antibiotics. Allergy 2003, 58:961–972.Practical guidelines on β-lactam allergy diagnosis (when reactions occurred within the first hour after drug administration).
Romano A, Blanca M, Torres MJ, et al.: Diagnosis of nonimmediate reactions to beta-lactam antibiotics. Allergy 2004, 59:1153–1160.Practical guidelines on β-lactam allergy diagnosis (when reactions occurred more than 1 hour after drug administration).
Saxon A: Immediate hypersensitivity reactions to beta-lactam antibiotics. Ann Intern Med 1987, 107:204–215.
Weiss ME, Adkinson NF: Immediate hypersensitivity reactions to penicillin and related antibiotics. Clin Allergy 1988, 18:515–840.
Bachot N, Roujeau JC: Differential diagnosis of severe cutaneous drug eruptions. Am J Clin Dermatol 2003, 4:561–572.
Pichler WJ: Delayed drug hypersensitivity reactions. Ann Intern Med 2003, 139:683–693.Outstanding proposal for a revision of the Gell and Coombs classification when applied to drug allergy.
Demoly P, Bousquet J: Epidemiology of drug allergy. Curr Opin Allergy Clin Immunol 2001, 1:305–310.
Primeau MN, Adkinson NF Jr: Recent advances in the diagnosis of drug allergy. Curr Opin Allergy Clin Immunol 2001, 1:337–341.
Gruchalla RS: Clinical assessment of drug-induced disease. Lancet 2000, 356:1505–1511.
Demoly P, Kropf R, Bircher A, Pichler WJ: Drug hypersensitivity questionnaire. Allergy 1999, 54:999–1003.
Brockow K, Romano A, Blanca M, et al.: General considerations for skin test procedures in the diagnosis of drug hypersensitivity. Allergy 2002, 57:45–51.
Blanca M, Mayorga C, Torres MJ, et al.: Clinical evaluation of Pharmacia CAP System RAST FEIA amoxicilloyl and benzylpenicilloyl in patients with penicillin allergy. Allergy 2001, 56:862–870.
Nyfeler B, Pichler WJ: The lymphocyte transformation test for the diagnosis of drug allergy: sensitivity and specificity. Clin Exp Allergy 1997, 27:175–181.
Sanz ML, Gamboa PM, Antepara I, et al.: Flow cytometric basophil activation test by detection of CD63 expression in patients with immediate-type reactions to beta-lactam antibiotics. Clin Exp Allergy 2002, 32:277–286.
Aberer W, Bircher A, Romano A, et al.: Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations. Allergy 2003, 58:854–863.
Messaad D, Sahla H, Benahmed S, et al.: Drug provocation tests in patients with a history suggesting an immediate drug hypersensitivity reaction. Ann Intern Med 2004, 140:1001–1006.
Moore N, Biour M, Paux G, et al.: Adverse drug reaction monitoring: doing it the French way. Lancet 1985, 2:1056–1058.
Jones JK: Criteria for journal reports of suspected drug reactions. Clin Pharm 1982, 1:554–555.
Naranjo CA, Busto U, Sellers EM, et al.: A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981, 30:239–245.
Kramer MS, Leventhal JM, Hutchinson TA, Feinstein AR: An algorithm for the operational assessment of adverse drug reactions. I. Background, description, and instructions for use. JAMA 1979, 242:623–632.
Haverkos HV, Amsel Z, Drotman P: Adverse virus-drug interactions. Rev Infect Dis 1991, 13:697–704.
Cars O, Molstad S, Melander A: Variation in antibiotic use in the European Union. Lancet 2001, 357:1851–1853.
McCaig L, Hughes JM: Trends in antimicrobial drug prescribing among office-based physicians in the United States. JAMA 1995, 273:214–219.
Guillemot D, Maison P, Carbon C, et al.: Trends in antimicrobial drug use in the community-France, 1981–1992. J Infect Dis 1998, 177:492–497.
Blanca M, Mayorga C, Torres MJ, et al.: Side chain specific reactions to beta-lactams: fourteen years later. Clin Exp Allergy 2002, 32:192–197.
Torres MJ, Romano A, Mayorga C, et al.: Diagnostic evaluation of a large group of patients with immediate allergy to penicillins: the role of skin testing. Allergy 2001, 56:850–856.
Chandra RK, Joglekar SA, Tomas E: Penicillin allergy: antipenicillin IgE antibodies and immediate hypersensitivity skin reactions employing major and minor determinants of penicillin. Arch Dis Child 1980, 55:857–860.
Blanca M, Torres MJ, García JJ, et al.: Natural evolution of skin test sensitivity in patients allergic to beta-lactam antibiotics. J Allergy Clin Immunol 1999, 103:918–924.
Redmond AP, Levine BB: Delayed skin reactions to benzylpenicillin in man. Int Arch Allergy 1968, 33:193–206.
Aihara M, Ikezawa Z: Evaluation of the skin test reactions with delayed type rash induced by penicillins and cephalosporins. J Dermatol 1987, 14:440–448.
Romano A, Di Fonso M, Papa G, et al.: Evaluation of adverse cutaneous reactions to aminopenicillins with emphasis on those manifested by maculopapular rashes. Allergy 1995, 50:113–118.
Romano A, Quaratino D, Di Fonso M, et al.: A diagnostic protocol for evaluating nonimmediate reactions to aminopenicillins. J Allergy Clin Immunol 1999, 103:1186–1190.
Romano A, Viola M, Mondino C, et al.: Diagnosing nonimmediate reactions to penicillins by in vivo tests. Int Arch Allergy Immunol 2002, 129:169–174.
Torres MJ, Sánchez-Sabate E, Álvarez J, et al.: Skin test evaluation in nonimmediate allergic reactions to penicillins. Allergy 2004, 59:219–224.
Lebel B, Messaad D, Kvedariene V, et al.: Cysteinyl-leukotriene release test (CAST) in the diagnosis of immediate drug reactions. Allergy 2001, 56:688–692.
Pichler WJ, Tilch J: The lymphocyte transformation test in the diagnosis of drug hypersensitivity. Allergy 2004, 59:809–820.
Green GR, Rosenblum AH, Sweet LC: Evaluation of penicillin hypersensitivity: value of clinical history and skin testing with penicilloyl-polylysine and penicillin G. A comparative prospective study of the penicillin study group of the American Academy of Allergy. J Allergy Clin Immunol 1977, 60:339–345.
Mendelson LM, Ressler C, Rosen JP, Selcow JE: Routine elective penicillin allergy skin testing in children and adolescents: study of sensitization. J Allergy Clin Immunol 1984, 73:76–81.
Parker PJ, Parrinello JT, Condemi JJ, Rosenfeld S: Penicillin resensitization among hospitalized patients. J Allergy Clin Immunol 1991, 88:213–217.
López-Serrano MC, Caballero MT, Barranco P, Martínez-Alzamora F: Booster responses in the study of allergic reactions to beta-lactam antibiotics. J Invest Allergol Clin Immunol 1996, 6:30–35.
Pichichero ME, Pichichero DM: Diagnosis of penicillin, amoxicillin, and cephalosporin allergy: reliability of examination assessed by skin testing and oral challenge. J Pediatr 1998, 132:137–43.
Romano A, Guéant-Rodriguez RM, Viola M, et al.: Cross-reactivity and tolerability of cephalosporins in patients with immediate hypersensitivity to penicillins. Ann Intern Med 2004, 141:16–22.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Demoly, P., Romano, A. Update on beta-lactam allergy diagnosis. Curr Allergy Asthma Rep 5, 9–14 (2005). https://doi.org/10.1007/s11882-005-0048-2
Issue Date:
DOI: https://doi.org/10.1007/s11882-005-0048-2